Biotechs buck a sluggish IPO market, but investors should tread warily

1 publisher first detected 1h ago 2% of 42 Business publishers

Headline as filed by CNBC Top News.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
CNBC Top News	Biotechs buck a sluggish IPO market, but investors should tread warily	While a number of IPOs have been pulled or delayed in 2026, the biotech sector has bucked the trend, with 26 companies debuting in U.S. markets.	28 Oct, 17:47	28 Oct, 18:00	0m	cnbc.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Related coverage

connected by shared subjects

Biotechs buck a sluggish IPO market, but investors should tread warily

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

Jim Cramer warns this overlooked danger could threaten the market rally

Turmoil hits AI build-out as neoclouds face pressure, credit risks mount and Solidigm pulls IPO

MSG Sports is splitting the Knicks and Rangers into two stocks, and history says spin-offs tend to beat IPOs

Top venture capitalist Jenny Lee says Asian startups are speeding toward IPOs

Recent crypto IPOs have been a wipeout for most investors. Will the next wave be better?

Florida Woman Arrested Following Conversation With Claude That Allegedly Included ‘Threats’